Atlas Trials

Predictive Value of Soluble CD146 in Glioblastoma Patients

Clinical trial NCT06001281 · RECRUITING

Trial details

NCT number
NCT06001281
Sponsor
Assistance Publique Hopitaux De Marseille
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2024-01-30
Primary completion
2026-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.